(Q34483832)

2 August 2017

Audit of control of heparin treatment (English)

1 reference

2 August 2017

1 reference

Fennerty AG

1

1 reference

2 August 2017

Thomas P

2

1 reference

2 August 2017

Backhouse G

3

1 reference

2 August 2017

Bentley P

4

1 reference

2 August 2017

Campbell IA

5

1 reference

2 August 2017

Routledge PA

6

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 January 1985

1 reference

2 August 2017

1 reference

2 August 2017

290

1 reference

2 August 2017

6461

1 reference

2 August 2017

27-28

1 reference

A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time

2 August 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1415373

Management of heparin therapy: Controlled prospective trial

6 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3917323

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Heparin kinetics in venous thrombosis and pulmonary embolism

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3917323

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Determinants of the anticoagulant effect of heparin in vitro

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3917323

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.290.6461.27-A

0 references

PMCID

1415373

1 reference

2 August 2017

1 reference